Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • TA119
  • Published: 
Download guidance (PDF)

8 Review of guidance

8.1 The review date for a technology appraisal refers to the month and year in which the Guidance Executive will consider whether the technology should be reviewed. This decision will be taken in the light of information gathered by the Institute, and in consultation with consultees and commentators.

8.2 The guidance on this technology was considered for review in May 2010. For details, see the NICE website.

Andrew Dillon
Chief Executive
August 2007